Hopp til hovedinnhold

Barretts øsofagus

Sist oppdatert: Sist revidert:
Sist revidert av:

Definisjon:
Intestinal metaplasi i distale øsofagus på bakgrunn av langvarig gastroøsofageal refluks
Forekomst:
Prevalens angis til 1-5%. Blant personer med reflukssykdom 5-15%
Symptomer:
De fleste har symptomer på reflukssykdom i form av sure oppstøt, halsbrann, sviende smerter i epigastriet - men noen er asymptomatiske
Funn:
Ingen kliniske funn knyttet til sykdommen
Diagnostikk:
Endoskopi og biopsi gir diagnosen
Behandling:
Medikamentell behandling med protonpumpehemmer, og antirefluks-kirurgi synes å kunne bremse progresjon av sykdommen og redusere faren for utvikling av adenokarsinom
  1. Spechler SJ, Souza RF. Barrett's esophagus. N Engl J Med 2014; 371: 836-45. doi: 10.1056/NEJMra1314704 DOI  
  2. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrret's esophagus in the general population: an endoscopic study. Gastroenterology 2005; 129: 1825-31. Gastroenterology  
  3. Ward EM, Wolfsen HC, Achem SR, et al. Barreet's esophagus is common in older men and women undergoing screening colonoscopy regardless of reflux-symptoms. Am J Gastroenterol 2006; 101: 12-7. PubMed  
  4. Westhoff B, Brotze S, Weston A, et al. The frequence of Barret's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc 2005; 61: 226-31. PubMed  
  5. Zimmerman TG. Common questions about Barrett esophagus. Am Fam Physician. 2014 Jan 15;89(2):92-8. PMID: 24444576. PubMed  
  6. Velanovich V. Barrett's oesophagus. BestPractice, last updated Sep 17, 2014 .
  7. Bonino JA, Sharma P. Barrett's esophagus. Curr Opin Gastroenterol. 2006;22:406-411. PubMed  
  8. Jankowski J, Barr H, Wang K, Delaney B. Diagnosis and managmenet of Barrett's oesophagus. BMJ 2010; 341: c4551. BMJ (DOI)  
  9. Spechler SJ. Barrett esophagus and risk of esophageal cancer: a clinical review. JAMA. 2013 Aug 14;310(6):627-36. PMID: 23942681 PubMed  
  10. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barret's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011; 103: 1049-57. PubMed  
  11. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011; 365: 1375-83. New England Journal of Medicine  
  12. Shaheen NJ, Richter JE. Barret's oesophagus (Seminar). Lancet 2009; 373: 850-61. PubMed  
  13. Meining A, Ott R, Becker I, et al. The Munich Barrett follow-up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only - what is the clinical significance? Gut 2004; 53: 1402-07.
  14. Bennett C, Moayyedi P, Corley DA, et al. BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 ;110:662-82; quiz 683. doi: 10.1038/ajg.2015.55 DOI  
  15. National Institute for Health and Clinical Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Clinical guideline CG184. Last updated: 18 October 2019. www.nice.org.uk  
  16. Singh S, Garg SK, Singh PP, et al. Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis. Gut. 2014 ;63(8):1229-37. doi: 10.1136/gutjnl-2013-305997 DOI  
  17. Allaix ME, Patti MG. Antireflux Surgery for Dysplastic Barrett. World J Surg. 2014 May 9. PMID: 24806626. PubMed  
  18. Wassenaar EB, Oelschlager BK. Effect of medical and surgical treatment of Barrett's metaplasia. World J Gastroenterol 2010; 16: 3773-9. PubMed  
  19. Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett's esophagus. Am J Gastroenterol 2016; 111:30-50. PMID: 26526079 PubMed  
  20. de Jonge PJ, Spaander MC, Bruno MJ, et al. Acid suppression and surgical therapy for Barrett's oesophagus. Best Pract Res Clin Gastroenterol. 2015;29:139-50. doi: 10.1016/j.bpg.2014.11.005 DOI  
  21. Jankowski JAZ, de Caestecker J, Love SB, et al. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26. (Original) PMID: 30057104 PubMed  
  22. Epstein D, Bojke L, Schulper MJ for the REFLUX trial group. Laparoscopic fundoplication compared with medical management for gastro-oesophageal reflux disease: cost effectiveness study. BMJ 2009; 339: b2576. BMJ (DOI)  
  23. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barreet's esophagus with high-grade dysplasia. Gastroenterology 2001; 120: 1607-19. Gastroenterology  
  24. Blevins CH, Iyer PG. Endoscopic therapy for Barrett's oesophagus. Best Pract Res Clin Gastroenterol. 2015 Feb;29(1):167-77. doi: 10.1016/j.bpg.2014.11.007 DOI  
  25. Weston AP, Sharma P, Mathur S, et al. Risk stratification of Barrett's esophagus: updated prospective multivariate analysis. Am J Gastroenterol 2004; 99: 1657-66. PubMed  
  26. Oslo universitetssykehus eHåndbok. Medisinsk fagprosedyre. Barrets øsofagus. Nettside besøkt 29.04.21. ehandboken.ous-hf.no  
  27. Sarna VK, Hauge, T. Barretts øsofagus. Indremedisineren 2021. indremedisineren.no  
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Per Martin Kleveland, professor i gastroenterologi, Norges teknisk-naturvitenskapelige universitet og overlege gastroenterologisk avdeling St. Olavs Hospital, Trondheim